First Trust NYSE Arca Biotechnology Index Fund (FBT)
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 31, 2024 | $1.17 | 2024-12-13 | 2024-12-13 |
| September 30, 2015 | $0.02 | 2015-09-23 | 2015-09-25 |
| June 30, 2015 | $0.06 | 2015-06-24 | 2015-06-26 |
| March 31, 2015 | $0.05 | 2015-03-25 | 2015-03-27 |
| December 31, 2014 | $0.05 | 2014-12-23 | 2014-12-26 |
Dividends Summary
- First Trust NYSE Arca Biotechnology Index Fund has issued 6 dividend payments over the past 16 years
- The most recent dividend was paid 263 days ago, on December 31, 2024
- The highest dividend payed out to investors during this period was $1.1726 per share
- The average dividend paid during this period was $0.27 per share.
Company News
The First Trust NYSE Arca Biotechnology ETF (FBT) is a passively managed exchange-traded fund that provides broad exposure to the healthcare-biotech sector. The ETF tracks the NYSE Arca Biotechnology Index and has a relatively high expense ratio of 0.56%. Its top holdings include Alnylam Pharmaceuticals, Corcept Therapeutics, and United Therapeutics.
This week's ETF Wrap looks at top performers in the first half of 2023, as well as flows, as stocks rally and crypto-related funds jump so far this year.
Here are the five best biotech ETFs to invest in right now.
We’re going through an inflation scare right now, and we can see the changes in markets. The recent rise in nominal bond yields is much more about inflation fears than growth hopes.
The coronavirus pandemic that began in 2020 and is persisting today has led many investors to hold poor market expectations. But maybe they shouldn’t be so pessimistic. What Happened: That’s according to a new RSM report stating the U.S. economy grew by over 6% in the second quarter of 2021, making the start of a business cycle as good as things were ...